zers, whereas erythropoietin dosage was positively related with lower procoagulatory activity. Background. Thrombotic complications are common in patients with endstage renal disease and contribute Conclusion. A majority of patients on dialysis are in a hypercoagulable state, which is further aggravated by substantially to the morbidity and mortality in this population. The aim of the present study was to: i) the haemodialysis procedure itself and may not be sufficiently controlled with current anticoagulation determine the prevalence and the extent of hypercoagulability in patients undergoing dialysis treatment by regimens. Intensified heparin treatment and the use of rhEPO are likely to improve coagulation haemostasis, measuring parameters that directly reflect thrombin concentrations; ii ) assess changes in coagulation status whereas the type of dialyzer should be considered as a relevant procoagulatory factor. during haemodialysis (HD); iii) quantify the relative impact of heparin, dialysis and their combined effects
ments F1+2, thrombin-antithrombin complexes and Introduction D-dimer concentrations. HD patients were investigated prior to and during dialysis. A subgroup of patients Thrombotic events are frequent among patients with was infused heparin alone without dialysis or was end stage renal disease ( ESRD) and contribute subdialysed without heparin administration. Furthermore, stantially to the high cardiovascular morbidity and subgroup and correlation analyses were performed for mortality in this population [1 ] . They either originate the type of dialysis ( HD vs CAPD), dialyzer and on the ground of hypertensive, diabetic or inflammatshunt, Kt/V, underlying disease and treatment with ory vasculopathies or occur secondarily from coagulrecombinant erythropoietin (rhEPO).
opathies due to proteinuria in glomerular disease [2 ] . Results. Baseline levels of all parameters -procoagulatFurthermore, a role of uremia by itself promoting a ory and fibrinolytic -were substantially elevated in all hypercoagulable state has been proposed [3] . Thus, patients, but to a higher degree among those on CAPD.
previous studies have described changes in coagulation Moreover, haemodialysis treatment increased procoaguand fibrinolytic factors in patients with chronic and latory markers even further, suggesting stimulated acute renal failure compatible with increased procoagucoagulation and/or insufficent anticoagulation during latory activity [4] [5] [6] [7] . Among these patients, those dialysis. However, after 3 h of dialysis thrombin concenundergoing chronic haemodialysis treatment represent trations, determined by quantification of prothrombin a high risk group for thromboembolic complications fragments, were inversely correlated with Kt/V. Selective because they are exposed to additional exogenous heparin infusion diminished procoagulatory activity only factors with impact on their coagulation system. slightly and incompletely, whereas HD without heparin Mainly, contact activation by extracorporeal devices resulted in excess thrombin accumulation. Finally, subhas to be counterbalanced by anticoagulants such as group analyses revealed more pronounced thrombin heparin. Coagulation control in haemodialysis patients formation among patients treated with polysulfon dialyis of further importance with regard to vascular access quality and prevention of access thrombosis, one of population. Patient characteristics are given in Table 1 . The bidity and mortality [8] . Consequently, it is crucial to only exclusion criteria was oral anticoagulation therapy.
determine coagulation status in patients on renal
All patients received unfractionated heparin ( LiqueminA, replacement therapy, especially haemodialysis, and to Roche) in order to prevent clotting of dialyzer membranes determine changes occuring during dialysis in order to and artificial surfaces of extracorporeal devices. The develop adequate anticoagulation regimens. However, 'adequate' dose of heparin during dialysis had been deteronly a limited number of studies examining these mined earlier and individually for each patient aiming for a questions is available and they have been conducted partial thromboplastin time (PTT ) being 2-to 2.5-fold the either in the setting of acute haemodialysis, only prior unheparinized baseline value. Dose adaptations were made to dialysis [9] or in a small number of patients [5] . as necessary according to the following criteria: coagulation Based on the available data it seems likely, that com-of the dialyzer during HD; retention of blood in the dialyzer monly used heparin regimens do not sufficiently sup-at the end of dialysis after rinsing with NaCl; or prolonged press thrombin formation during HD.
bleeding after HD. All patients under investigation had
In order to test this hypothesis, we assessed coagula-received the same dose of heparin for at least 3 months prior to the study and were negative with respect to the criteria tion status of HD patients before and during dialysis. antithrombin complex (TAT ) and D-dimer concentra-1500-5000 IU ) that was followed by continuous infusion of tions were determined, parameters that directly reflect 875±61 IU (range: 500-1500 IU ) per hour. Infusion was thrombin formation and thrombolysis, respectively.
stopped 30 min before completion of HD.
They have previoulsy proven their usefulness in the Different protocols were performed with subgroups of diagnosis of deep venous thrombosis [10, 11] , as pre-patients and are described subsequently. In each protocol all dictive parameters of postoperative thromboembolic parameters were determined before initiation of HD and complications from hip surgery [12 ] and to guide oral heparin treatment and at least after 180 min of treatment anticoagulation for mechanical heart valve pros-(except for CAPD patients). thesis and after coronary bypass graft surgery [13 ] . To
Protocol A, including ten individuals, was designed to determine factors that further affect coagulation detect changes in coagulation parameters during regular HD haemostasis and to identify patients at risk for throm-with heparinization. Determinations were performed repetitboembolic complications we evaluated the impact of ively on three consecutive HD sessions. These patients were uniform with regard to the duration of haemodialysis ( 3.5 h), underlying disease process, type of dialysis (HD vs blood flow (250 ml/min) and dialyzer membrane ( F8, CAPD), dialyzer and vascular access, the Kt/V and Fresenius). Blood was drawn prior to initiation of HD and therapy with recombinant erythropoietin.
the administration of heparin (timepoint 0). Further blood sampling was performed 30 ( 1), 90 (2) and 120 min (3) into
Subjects and methods
HD, after 180 min (4), when heparin infusion was stopped, and at completion of HD after 210 min (5 ). Blood was drawn without prior congestion from the afferent canula
Patients
(arterialized blood) proximal to the addition of heparin and the dialyzer membrane. To exclude that results were affected Thirty-nine patients suffering from ESRD undergoing regular haemodialysis (HD) were recruited randomly out of our HD by the site of blood collection, we drew further blood in Reagents for determination of PTT (PathromtinA) were heparin on coagulation in dialysed patients, i.e. hepariniz-provided by Behring Diagnostics (Marburg, Germany). The ation without haemodialysis, excluding contact activation intraassay coefficient of variation (CV ) for this test ranges induced by extracorporeal devices and the dialysis procedure between 0.9 and 3.5%, the interassay CV is 2.8-4.9% [14] . itself. For this purpose, five patients were recruited from the The reference interval for adults ranges from 28-40 seconds. protocol A group, serving as their own control. Studies were F1+2 are components of the procoagulatory system. In performed within 7-14 days after the three consecutive brief, activation of prothrombin represents the key event in dialyses for protocol A. Heparin was administered via a the activation of the coagulation cascade. During this reachaemodialysis canula inserted in the HD shunt (AV-fistula tion factor Xa cleaves the peptide bond Arg273-Thr274 of or synthetic graft) in equivalent doses and for the same time the prothrombin molecule which results in liberation of as during regular HD treatment. Blood was drawn from a prothrombin fragment F1+2 and prothrombin 2. The latter separate canula placed in a peripheral vein.
is cleaved at Arg322-Ile323 with formation of a-thrombin. Protocol D was designed to analyze the isolated effect of Therefore, generation of F1+2 is proportional to thrombin haemodialysis on blood coagulation, i.e haemodialysis with-formation and allows a quantitative measurement of the out heparinization, excluding the anticoagulatory action of crucial component in the coagulation cascade. The assay for heparin. In this setting coagulation parameters exclusively the determination of F1+2 in plasma as decribed by Bruhn reflect contact activation by the extracorporeal device and et al. is based on antibodies raised against a synthetic peptide the haemodialysis procedure itself. Thus, protocol D is from the negatively charged region of F1+2 (EnzygnostA complementary to protocol C, together representing different F1+2 micro, Behring Diagnostics). The accuracy of the components of protocol A (i.e. heparinization and contact assay with regard to mean intra-assay and inter-assay reproactivation). Three patients were chosen from the protocol A ducibility has been proven in a multicentric evaluation [ 15] . group to undergo HD without heparinization. Again, studies The intensity of the enzymatic reaction was quantified photowere performed within 7-14 days after the three consecutive metrically. The standards contained in the kit cover a concendialyses for protocol A. To prevent blood clotting dialyzers tration range from 0.04-10 nmol/l. The intraassay and and blood lines were rinsed every 30 min with 100 ml of interassay reproducibility for the test, as published previ-0.9% sodium chloride ( NaCl ). Haemodialysis was aborted oulsy, are 11% and 12.6%, respectively [15 ] . Testing 133 when regular dialysis time was completed or when dialyzer healthy subjects a reference range from 0.37-1.11 nmol/l membranes or blood lines started to clot. F1+2 (2.5-97.5th percentile) was reported. In order to Finally, a control group of ten patients undergoing chronic standardize the test for our own laboratory we determined ambulatory peritoneal dialysis (CAPD), was investigated. protrombin fragment concentrations in individuals from a They were analyzed to determine the impact of uremia on healthy control population (n=36). The mean±SD for blood coagulation independent of chronic haemodialysis F1+2 concentrations in this group is 0.97±0.12 nmol/l, treatment and heparinization. The rationale to use CAPD ranging from 0.71-1.24 nmol/l. Our own reference range patients for control rather than untreated patients with (5th-95th percentile) derived from these data is ESRD was to avoid bias from severe uremia due to lack of 0.71-1.12 nmol/l. treatment. Moreover, this approach was used to compare Thrombin anti-thrombin complexes ( TAT-complexes) are the effect of HD and CAPD on coagulation status. PD rapidly generated in the final process of blood coagulation patients were selected randomly from our CAPD cohort by the association of antithrombin III ( ATIII ) to thrombin, ( patient characteristics see Table 1 ). They underwent a single a process that is enhanced by heparin and inactivates thromblood collection when presenting for routine control in our bin. Therefore, like F1+2 TAT-complexes reflect an in vivo outpatient clinic. thrombin generation process [16 ] . For determination of TATAll analyses of factors with a potential impact on coagula-complexes the enzyme immunoassay 'Enzygnost TAT tion parameters were based on data obtained from patients microA' from Behring Diagnostics was purchased [17] . of protocols A and B (n=29) determined before and 180 min Concentrations were quantified photometrically. The intraasafter start of haemodialysis.
say and interassay CVs for this test reportedly are 4-6 and The majority of the HD study patients (24 out of 29) 6-9%, respectively, the reference range ( 2.5th-97.5th percentreceived treatement with intravenous recombinant human ile) 1.0-4.1 mg/l (data according to the manufacturer). In erythropoietin (rhEPO; EprexA, Cilag, or RecormonA, order to determine whether procoagulatory events were Boehringer Mannheim) over an extended period of time. The counterbalanced by changes in fibrinolysis we measured target range determining the amount of rhEPO to be adminis-D-dimer plasma concentrations. D-dimers are generated by tered was defined as a hematocrit between 30 and 35%. The the proteolytic action of plasmin on fibrin polymer average weekly dose was 7027±1002 IU, administered three crosslinked by factor XIII, reflecting thrombolytic activity times a week after completion of each haemodialysis session. [18] . Measurements of D-dimers were performed by an During study sessions, rhEPO was administered after collec-ELISA method (D-Dimer ELISA, Boehringer Mannheim, tion of the last blood sample.
Rotkreuz, Switzerland). The study protocol was approved by the hospital's ethical All assays were performed in duplicate and the mean of committee. All patients gave their informed consent for the two values was used.
Kt/V was calculated from the ultrafiltration coefficient of participation. the patient's dialyzer ( K ), the duration of the individual range. Standard haemodialysis had a minimal effect on dialysis session (t) and the urea volume of distribution prothrombin fragment generation during the first 2 h of estimated as 58% of dry body weight ( V ). dialysis (n=10), but concentrations were significantly increased after 3 h compared to baseline (P<0.05; n= 29). However, the amount of prothrombin fragments Statistics after 3 h of dialysis was lower among patients with Data are presented as means±SEM. Analyses were per-higher values for Kt/V (r=−0.54, P<0.01 ).
formed by simple ANOVA or ANOVA for repeated measureConcentrations of thrombin-antithrombin comments. Correlation of different parameters was tested by plexes (TAT ) prior to HD were significantly increased simple and multiple regression analysis, or by Spearman's in patients on regular HD ( Table 2 ) ments and TAT complexes are indicative of predominant procoagulatory activity rather than reduced fibrinolysis.
Regular haemodialysis (A and B)
All standard haemodialysis treatments according to Heparinization without haemodialysis (C) protocol A and B were performed without complications in all patients. Neither clotting of dialyzers or Results are summarized graphically in Figure 3 . Unlike blood lines nor bleeding complications were observed. regular dialysis, selective heparin infusion did not result
Baseline PTT values were within normal range in significant changes of any coagulation parameter before the administration of heparin and/or inititiation determined. Prothrombin fragments were lower of haemodialysis (Table 2 ). After start of regular towards the end of heparin administration without haemodialysis, PTT doubled within 30 min of treat-dialysis and therefore relatively (but not significantly) ment (P<0.01 vs baseline), and remained elevated for decreased vs standard HD. 60 min. Values slowly decreased but remained prolonged until the end of dialysis, heparin being with-Haemodialysis without heparinization (D) drawn 30 min earlier ( Figure 1) .
Baseline concentrations of prothrombin fragments When dialysis was performed without anticoagulation, treatment had to be aborted earlier than scheduled in F1+F2 ( F1+2) were significantly elevated in patients on regular haemodialysis ( Table 2) . Only one out of 29 two out of three patients because dialyzer and blood lines were clotted. Clotting occured after 120 and HD patients had concentrations within the normal protocol D (n=3), with two of them having F1+2 and TAT baseline concentrations above average. PTT did virtually not change during dialysis without heparin in these three patients ( Figure 4 , open dots), whereas regular treatment had resulted in a 2.5-fold increase immediately after initiation of anticoagulation in the same patients ( Figure 4 , closed dots). Values stayed significantly lower throughout dialysis compared to the standard regimen. In contrast, generation of prothrombin fragments was pronounced in patients undergoing HD without heparin. This effect became more significant over time. Similarly, TAT complex on haemodialysis ( Table 2 ). These differences reached statistic significance for PTT and F1+2 values. 135 min, respectively. Dialysis was regularly completed However, when posthaemodialysis measurements were after 180 min in the third patient. However, the dialyzer compared with values from PD patients the opposite membrane could not be rinsed completely despite was found, indicating more pronounced hypercoagulextensive use of NaCl, a considerable amount of blood ability after haemodialysis. remaining in the extracorporeal device. Figure 4 depicts changes in coagulation parameters Effect of age and underlying disease from treatment according to protocol D. Baseline levels for F1+2 and TAT in this group were higher than The age of patients did not correlate with coagulation activity, neither before nor during haemodialysis, those determined in protocol A ( Figure 1 ). This discrepancy is due to the small number of patients in revealed by any parameter assessed. However, baseline . Patients (n=3) underwent either standard dialysis with hephaemodialysis (#) compared to standard dialysis in the same subjects arin administration ($) or were dialysed without heparinization (#) ($). Determinations were made before start of dialysis and adminisin a crossover experiment. F1+2 and TAT concentrations increased tration of heparin (0 ); after 30, 90, 120, and 180 min into HD, and dramatically after 90 min of dialysis without heparinization and at the end of HD ( 210 min), respectively. Heparin was infused resulted in dialyzer clotting in two of three patients before completion continuously at the same rate during standard dialysis and selective of dialysis. PTT did not change without heparin infusion. Note the heparinization. F1+2 and TAT concentrations increased towards difference in y-axis range vs Figures 1 and 3 . the end of dialysis, whereas heparin infusion by itself did not change levels significantly.
Impact of vascular access, type of dialyzer and dialysate
No differences in coagulation parameters were detectcoagulation parameters could be identified as discriminatory factors of the renal disease process. Patients able between patients with shunts from native vessels and those with prosthetic shunts, nor for acetate with vascular nephropathy had significantly higher prothrombin fragment baseline concentrations vs bicarbonate dialysate. However, differences in prothrombin fragment generation were obvious among ( 4.3±0.1) than patients with diabetic nephropathy ( 2.95±0.4; P=0.03) or interstitial kidney disease different types of dialyzers ( Figure 5 ). In patients treated with polysulfon membranes a 15% increase in ( 2.4±0.3; P<0.01). Similarly, D-dimer concentrations were almost twice as high in patients with vascular F1+2 concentrations was observed during standard dialysis, whereas concentrations decreased in patients nephropathy compared to other etiologies (data not shown). In contrast, partial thromboplastin time and treated with hemophan and cellulose filters by 11 and 8.4%, respectively. Consequently, levels of F1+2 were TAT complex levels were similar among patients with different renal pathologies. markedly lower after 3 h of dialysis in patients treated erythropoietin dose and prothrombin levels was detected ( Figure 6 ). Higher rhEPO doses were associated with lower prothrombin fragment concentrations (r=−0.37, P=0.045). In accordance, patients on higher rhEPO doses had more prolonged partial thromboplastin times (r=0.48, P=0.008). These rhEPO dose effects on F1+2 and PTT were unrelated to the amount of heparin administered, patient's hematocrit, age, underlying renal disease, time on dialysis or type of dialyzer used, as revealed by multiple linear with hemophan (2.4±0.4 nmol/l ) and cellulose membranes ( 2.0±0.5 nmol/l ), respectively, compared to patients with polysulfon dialyzers ( 3.6±0.3 nmol/l; P=0.04 and 0.02, respectively). Also, F1+2 baseline concentrations were highest for polysulfon membranes ( 3.0±0.3 nmol/l ), but not statistically different from dialyzers made of hemophan (2.7±0.5 nmol/l ) or cellulose (2.1±0.5 nmol/l ). This observation indicates accelarated thrombin formation with polysulfon membranes during dialysis.
rhEPO treatment and coagulation status
Previous studies in patients on HD have suggested that rhEPO is associated with increased coagulatory and decreased fibrinolytic activity [19, 20] . Out of 29 patients in our study 24 were on rhEPO treatment. As shown in Table 3 they had slightly, but insignificantly increased levels of prothrombin fragments and TAT complexes but prolonged partial thromboplastin times compared to patients without rhEPO. However, when we analysed the effect of rhEPO dosage on procoagu- Fig. 6 . Scatter plots showing relation between erythropoitin dosage latory activity in patients receiving erythropoietin ( X-axis) and baseline plasma concentrations of F1+2 and partial thromboplastin time ( PTT ), respectively. therapy a significant (inverse) correlation between Table 3 . Coagulation parameters of patients without and with recombinant human erythropoietin (rhEPO) treatment
No rhEPO (n=5 ) 35.4±1.5 2.55±0.36 10.9±1.9 203±95 rhEPO (n=24) 37.6±1.5 2.85±0.27 13.0±3.3 170±37
Results consist of patients from group/protocol A and B (regular HD with heparin).
P. M. Ambü hl
ably account for the quantitative differences observed of rhEPO. Therefore, these findings imply a specific dose related effect of recombinant erythropoietin on in the degree of prothrombin and TAT complex formation during HD: Halflifes (T D ) for F1+2 and TAT are procoagulatory activity in haemodialysis patients.
90 and 20 min, respectively [17] . In accordance with the longer halflife for F1+2 their concentrations were Discussion only slightly lowered by heparin without dialysis (protocol C ) compared to standard HD ( Figure 3 ). An alternative explanation, however, would be that hepHypercoagulability is presumed to occur in renal disease and potential mechanisms have been reviewed arin releases TAT-complexes from thrombotic material, thereby steadily increasing their serum levels. In recently [21 ] . In our mixed patient population we found procoagulatory activity to be increased by >2-accordance, TAT complex concentrations dropped immediately both after withdrawal of heparin infusion and 3-fold above normal evidenced by increased levels of prothrombin fragments and TAT-complexes, during regular HD ( protocol A) and after selective heparinization (protocol C ). Finally, it is important respectively ( Table 2 ). These findings are in accordance with studies from other groups that measured either to notice, that TAT-complex formation also depends on the amount of ATIII and heparin present in the TAT complexes [6 ] or TAT complexes in combination with F1+2 [9 ] in patients with ESRD. Similar results blood. Indeed, reduced levels of ATIII and ATIII activity have been described in patients with ESRD have been described also for subgroups of patients with chronic renal failure. For example, diabetic and [22] . Nevertheless, this can not explain the higher concentrations of TAT in our patients since the changes non-diabetic patients with ESRD have been reported to have increased procoagulatory activity, as evidenced in ATIII are in the wrong direction. Also, the same study found no significant changes in ATIII concentraby elevated platelet aggregation, increased concentrations of D-dimers, von Willebrand factor antigen and tions and activity during haemodialysis. However, differences in blood heparin concentrations among platelet factor 4 in both groups [7 ] . Along with our results of a hypercoagulable state of comparable degree patients and changes in heparin levels during HD may contribute to the amount of measured TAT complexes, in CAPD patients ( Table 2) , renal failure per se rather than HD treatment seems to be the cause of increased which therefore reflect thrombin generation with more variability than prothrombin fragments do. procoagulatory activity. Noteably, we also detected strongly elevated D-dimer levels ( Table 2 ) , demonstratDetermination of adequate heparin therapy for haemodialysis is important with regard to dialysis ing that stimulated thrombin formation and not impaired fibrinolytic activity accounts for the hyper-efficiency and reduction of thrombotic risk. Heparin dosage in our patients was based on standard regimens coagulable state. However, no conclusion can be drawn from the present study with regard to whether increased modified empirically. Consequently, no clotting of extracorporeal devices occured during the study. prothrombin fragment and TAT complex concentrations are the result of increased production or Nevertheless, our findings suggest that commonly used heparin doses are not sufficient to effectively control decreased clearance.
Determination of prothrombin fragments and TAT hypercoagulability. To further test this hypothesis we developed a study designed to separately assess the complexes in this study revealed ongoing or even accelerated coagulation during haemodialysis effects of anticoagulation and haemodialysis on procoagulatory activity (protocol C and D, respectively). As ( Figure 1 ). Whereas F1+2 concentrations remained steadily elevated over the whole period of dialysis anticipated, PTT was prolonged by an additional 27% compared to standard HD after 30 min (ns) from despite heparinization, TAT complex concentrations even rose by 460%, detected 30 min before termination selective heparinization. Thereafter, no differences were detectable beween the two groups ( Figure 3 ). However, of dialysis. The consistent biphasic pattern observed for F1+2 and TAT, undulating between start and end when standard dialysis was compared to HD without anticoagulation, PTT did not change at all in the latter of dialysis in patients examined over three consecutive sessions of HD strongly suggests HD-induced group ( Figure 4) . In contrast, F1+2 and TAT complex concentrations fell from selective heparin treatment, thrombin formation (Figure 2 ). These findings are in accordance with Sagripanti et al., who found more but rose significantly during dialysis without anticoagulation. These results, first, demonstrate, that the diapronounced activation of various coagulation parameters in patients with ESRD on haemodialysis than lysis procedure substantially increases procoagulatory factors, shown by the tremendous rise in prothrombin in patients with conservative treatment with a verylow-protein diet [6 ] . However, it is of interest to notice, and TAT levels when anticoagulation was withheld (protocol D, Figure 4 ). Second and most importantly, that despite increased coagulation parameters during haemodialysis in our study prothrombin fragments the findings support our notion, that current heparin dose regimens are insufficient to limit coagulation were lower among patients with higher values for Kt/V (r=−0.54, P<0.01). This suggests that these products processes during haemodialysis. Although a relevant reduction in thrombin accumulation is achieved by are either dialyzed or generated to a lower extent due heparin administration (as evidenced by the difference extended studies need to confirm these conclusions.
Treatment with rhEPO has previously been shown to in the course of F1+2 and TAT concentrations in Figures 1 and 4) , heparin by itself diminished thrombin affect blood coagulation and fibrinolysis during the first weeks of administration, having a net procoagulatinduction even further (Figure 3 ) . The question remains, how excess thrombin formation and the 'ideal' ory effect [19, 20] . Despite the fact that only a small number of our study patients did not receive rhEPO, heparin dose could be determined. Clearly, the commonly used determination of PTT is not suitable to our results show the same trend ( Table 3) . However, an important observation was made when patients quantify thrombin formation, as shown by our data. It also has a limited use in monitoring heparin treat-receiving rhEPO were analysed separately as a group with regard to the dose effect of erythropoietin on ment. Due to the short halflife of TAT complexes their blood concentrations reflect ongoing thrombin accu-coagulation status. Whereas TAT complex concentrations were unrelated to rhEPO dosage, higher dose mulation the most accurate among the coagulation parameters evaluated in our experiments. The differ-regimens were associated with lower amounts of prothrombin fragments. This apparently paradoxical ences in TAT levels during regular HD with heparin and heparinization alone ( Figure 3 ) allow an approxi-finding may be explained by a dose related effect of rhEPO. Whereas low doses of erythropoietin seem to mate estimate of excess thrombin resulting from standard dialysis. TAT complex levels during standard induce prothrombotic factors, higher doses of the drug actually might decrease procoagulatory activity in dialysis were higher by 30-50% compared to concentrations during selective heparin infusion. Therefore, it is haemodialysis patients.
In summary and conclusion, we have shown that reasonable to assume that standard heparin doses as used in our study should be increased by 50% in patients with endstage renal disease are in a substantial procoagulable state. Coagulatory activity is further order to suppress thrombin accumulation during haemodialysis. This approach is supported by other stimulated by haemodialysis. Nevertheless, HD appears to be superior to PD in limiting thrombin data suggesting that TAT-complex levels determined at the end of dialysis are a good indicator for dose formation, possibly by better uremic control. On the other hand, current anticoagulation regimens for adaptations [5] . Moreover, Ireland et al. have found TAT levels to correlate well with heparin doses in haemodialysis are likely to be insufficient. These findings could be relevant with regard to the occurrence haemodialysis patients, lower TAT levels reflecting higher heparin concentrations [23 ] . However, further of thrombotic events and the efficiency of haemodialysis. Coagulation parameters assessing thrombin investigations need to establish the dose/effect relationship for regular heparin treatment.
formation more directly, such as TAT complex and F1+2 concentrations, should be employed individually Finally, we analyzed our data in order to identify treatment modalities that affect thrombin formation in for prescription of anticoagulation therapy, especially in patients with high risk profiles for thromboses. For ESRD patients. All coagulation parameters in patients on peritoneal dialysis reflect higher procoagulatory routine monitoring, however, these measurements are too elaborate and costly to justify their regular impleactivity compared to baseline (predialysis) values of patients undergoing HD (Table 2 ) . However, it mentation. Also, the pathophysiological relevance of these 'alternative' coagulation parameters needs to be remains to be determined whether haemodialysis delimits hypercoagulation more effectively than PD. further corroborated in order to prove importance beyond a simple laboratory phenomenon. Finally, proPatients with vascular nephropathy had significantly higher prothrombin levels compared to patients with spective studies are indicated to confirm our findings about dialyzer and rhEPO dose related effects on ESRD from other causes. This may reflect contact mediated induction of coagulation by the altered vas-procoagulatory activity. culature or decreased uptake and degradation of thrombin metabolites by damaged endothelium. These results become especially important considering recent References data suggesting that people at risk for the development
